genOway Shanghai at the Chinese Biopharmaceutical Association meeting 2024
Conference
The genOway Shanghai team participated in the CBA annual meeting, which hosted over 10,000 attendees, introducing genOway’s preclinical models to the Chinese scientific community.
During the conference, Marième NDJIM, PhD, Senior Business Developer at genOway, delivered an insightful presentation on how the predictability of our models accelerates the development of safer and more effective next-generation drugs.
We are very happy about the collaboration between our teams in France and China and the enthusiasm of all the clients we met.
Other news & events
Scientific excellence
From model design to experimental results
Featured in 600+ scientific articles
Collaborative approach
Collaboration with 17 Top Pharmas,
170+ Biotechs and 380+ Academic Institutions
Robust validation data on catalog models
Generated with biopharma partners and in-house
Innovative technologies
and guaranteed freedom to operate
Easy access to models
Models with certified health status from professional breeders in US and Europe